DNA methylation in prostate cancer

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Prostate cancer is a leading cause of cancer death in US men.
• Established risk factors include age, race, and family history, but molecular bases are unclear.
• Epigenetic events, like DNA methylation, alter gene expression and are implicated in cancer.

Purpose of the Study:

• To review current research on hypermethylated genes in human prostate cancer.
• To explore the role of DNA methylation in age-related, race-related, and hereditary prostate cancer.
• To discuss the potential of hypermethylated genes as biomarkers for prostate cancer detection and risk assessment.

Main Methods:

• Review of current scientific literature on gene methylation in prostate cancer.
• Analysis of epigenetic mechanisms, specifically CpG island hypermethylation.
• Examination of gene expression alterations in cancer-related cellular processes.

Main Results:

• Disruption of epigenetic regulation, including inappropriate CpG island hypermethylation, is observed in tumorigenesis.
• Aberrant gene expression due to methylation affects DNA repair, hormone response, cell cycle, and metastasis.
• Hypermethylated genes are linked to prostate cancer initiation, progression, and metastasis.

Conclusions:

• DNA methylation plays a significant role in prostate cancer development and progression.
• Epigenetic alterations may underlie the known risk factors for prostate cancer.
• Hypermethylated genes show promise as biomarkers for prostate cancer diagnosis and risk stratification.